Shukra Pharmaceuticals Ltd.

•

shukrapharmaceuticals.comBSE: -NSE: SHUKRAPHAR

Market Cap₹ 1,954 Cr.

Current Price

High / Low₹ 47 / 40

Stock P/E54.2

Book Value₹ 2

Price to Book15.23

Dividend Yield0.02 %

ROCE21.8 %

ROE15.9 %

Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Company has a healthy return on capital (ROCE) of 28.3%
Company has a good return on equity (ROE) track record: 3 Years ROE 27.3%
Latest quarter profit grew 1359.2% YoY, showing strong momentum
Operating margins have improved to 39.1% from 14.5%
Company has delivered good sales growth of 22.4% CAGR over last 5 years

CONS

A large part of profit comes from other income (31.5% of PBT)
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.18x)
Working capital days have increased from 206 to 539 days
Stock is trading at 15.2x its book value
Total debt has risen sharply - up 32.4% year on year

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1930.45	38.29	463179.62	0.83	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9165.00	83.18	243301.95	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4958.95	86.48	188622.52	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1164.05	25.73	116114.43	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1418.00	33.99	114554.33	0.92	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1860.00	91.92	100498.07	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2150.00	17.78	98312.16	0.84	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	DRREDDY	1171.00	30.33	97741.02	0.68	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	MANKIND	2360.00	47.72	97478.64	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
10.	AUROPHARMA	1683.00	26.08	96836.10	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2464.20	38.68	69545.80	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	SHUKRAPHAR	44.45	88.59	1954.09	0.02	12.96	—	23.52	77.26	21.80	81.39

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	20	25	19	11	3	6	11	13	5	6	39	6	24
	20	20	9	6	2	5	7	6	4	6	12	6	4
Operating Profit	0	5	10	4	1	1	4	7	1	-0	27	1	21
OPM %	1.74%	20.66%	50.56%	40.72%	25.47%	12.05%	37.24%	55.09%	24.49%	-6.97%	69.32%	10.95%	90.15%
Other Income	1	0	1	1	1	1	1	1	1	2	1	1	1
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	0	1	1	1	1	1	1	1	1	1	1	1	1
	0	5	10	5	1	1	4	8	1	0	27	0	20
Tax %	2.33%	-0.21%	1.15%	23.75%	38.75%	38.64%	22.68%	28.80%	24.82%	-1090.00%	24.11%	564.86%	25.75%
Net Profit	0	5	9	4	0	1	3	5	1	2	20	-2	15
	1	1	9	1	0	0	1	0	0	0	0	-0	0
Equity Capital	7	11	11	44	44	44	44	44	44	44	44	44	44
Reserves	0	0	0	0	0	0	0	0	0	0	0	0	0
Promoter Pledge %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	5	5	5	6	12	11	20	59	75	33	75
	4	4	4	4	10	10	18	53	55	20	28
Operating Profit	1	2	2	2	2	2	3	7	22	17	—
OPM %	28	30	32	30	13	16	14	11	30	52	—
Other Income	0	0	0	0	0	0	0	1	3	4	4
Interest	0	0	0	0	0	0	0	0	0	1	1
Depreciation	0	0	1	1	1	1	2	2	2	3	4
	0	1	1	1	0	0	1	4	20	13	48
Tax %	66	52	44	36	79	-92	26	1	7	28	24
Net Profit	0	1	1	0	0	0	1	4	19	10	36
EPS	0	0	0	0	0	1	5	26	17	0	—
Dividend Payout %	0	16	15	17	0	0	10	4	6	5	—
Minority Interest	0	0	0	0	0	0	0	0	0	0	0
Share of Associates	0	0	0	0	0	0	0	0	0	0	0
Adjusted EPS	0	0	0	0	0	0	0	0	0	0	—

COMPOUNDED SALES GROWTH

10 Years:: 29%
5 Years:: 22%
3 Years:: 17%

COMPOUNDED PROFIT GROWTH

10 Years:: 54%
5 Years:: 206%
3 Years:: 134%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: 10%
5 Years:: 18%
3 Years:: 27%
Last Year:: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
LIABILITIES	-	-	-	-	-	-	-	-	-	-
Equity Capital	2	2	2	2	2	2	2	4	11	44
	13	13	13	14	14	14	15	21	47	19
	0	0	0	0	0	0	0	1	0	0
Trade Payables	1	1	2	3	6	5	9	34	7	9
	3	3	7	10	12	15	10	15	13	15
Total Liabilities	17	19	24	28	34	36	35	75	78	87
ASSETS	-	-	-	-	-	-	-	-	-	-
	10	10	14	16	17	18	18	20	20	19
Capital Work in Progress	2	2	2	2	2	2	2	2	2	2
	0	0	0	0	1	2	4	3	2	10
	0	0	0	0	0	0	0	0	25	9
Cash & Bank	2	1	0	0	0	1	0	4	10	12
	4	6	8	11	13	14	12	46	19	35
Total Assets	17	19	24	28	34	36	35	75	78	87
Total Debt	0	0	4	6	8	10	3	5	3	4
Net Working Capital	5	5	6	7	7	9	3	11	42	48
Contingent Liabilities	0	0	0	0	0	0	1	0	1	1
Book Value per Share	89.89	93.10	95.86	98.20	98.43	99.63	104.43	64.63	52.67	1.44
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	1.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	3	-0	1	0	1	1	8	3	-5	8
Cash from Investing	-0	-1	-5	-2	-3	-2	-2	-4	-1	-1
Cash from Financing	-1	0	3	2	2	2	-7	5	12	-5
	1	-1	-0	0	-0	0	-0	4	6	2
Free Cash Flow	2	-1	-4	-2	-2	-1	6	-1	-7	5
OCF / Net Profit	22.82	-0.59	1.59	0.56	34.83	2.86	10.64	0.72	-0.28	0.83
Cumulative 5-Year FCF	0	0	0	0	-7	-11	-3	-0	-5	2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	0.76	3.21	3.36	2.95	0.23	1.20	4.79	11.26	16.94	0.22
Book Value (₹)	89.89	93.10	95.86	98.20	98.43	99.63	104.43	64.63	52.67	1.44
Dividend per Share (₹)	0.00	0.50	0.50	0.50	0.00	0.00	0.50	0.50	1.00	0.01
Cash EPS (₹)	0.02	0.03	0.04	0.05	0.05	0.06	0.08	0.40	0.47	0.29
PROFITABILITY
Operating Margin %	28.26%	29.70%	29.95%	25.53%	11.29%	16.08%	14.48%	11.15%	26.02%	39.06%
Net Margin %	2.46%	9.76%	9.12%	6.99%	0.26%	1.68%	3.66%	7.49%	24.86%	29.38%
ROE %	0.85%	3.51%	3.55%	3.04%	0.23%	1.21%	4.70%	21.16%	44.70%	15.90%
ROCE %	2.40%	7.41%	5.94%	3.62%	0.77%	0.54%	5.79%	18.85%	44.24%	21.80%
	0.67%	2.78%	2.44%	1.76%	0.11%	0.54%	2.12%	8.01%	24.26%	11.63%
EFFICIENCY
Debtor Days	55	121	171	228	177	288	153	117	134	186
Inventory Days	67	27	15	11	22	50	50	22	13	69
Payable Days	97	245	526	872	563	762	246	170	168	370
	26	-98	-341	-632	-364	-423	-43	-31	-20	-115
FINANCIAL HEALTH
Debt to Equity (x)	0.00x	0.00x	0.24x	0.39x	0.52x	0.63x	0.21x	0.20x	0.05x	0.07x
Interest Coverage (x)	256.48x	182.99x	24.45x	1166.32x	84.02x	3.94x	4.55x	16.82x	70.77x	23.42x
	8.06x	4.12x	3.11x	2.77x	2.07x	2.28x	1.28x	1.25x	3.97x	3.79x
GROWTH
Revenue Growth %	87.35%	6.46%	4.03%	5.91%	109.31%	-5.49%	82.97%	187.19%	26.75%	-56.30%
Operating Profit Growth %	57.96%	11.52%	12.87%	-2.27%	-8.15%	16.13%	64.81%	121.12%	238.70%	-23.77%
Net Profit Growth %	-8.98%	321.94%	4.56%	-12.12%	-92.29%	428.31%	299.10%	486.99%	320.68%	-48.35%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	50.47%	-98.71%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.48x	99.91x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	6.20x	15.23x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.31%	0.05%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	15.78x	56.02x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	50.96	50.96	50.96	50.96	50.96	50.96	50.96	50.96	50.96
FIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	48.93	48.93	48.93	48.93	48.93	48.93	48.93	48.93	48.92

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-03

General Updates

2026-09-03 - Shukra Pharmaceuticals Limited has informed the Exchange about General Updates

2026-09-02

Outcome of Board Meeting

2026-09-02 - Shukra Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 02, 2026.

2026-08-31

Copy of Newspaper Publication

2026-08-31 - Shukra Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-27

Shareholders meeting

2026-08-27 - Shukra Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot

2026-08-22

Outcome of Board Meeting

2026-08-22 - Shukra Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 22, 2026.

2026-08-17

General Updates

2026-08-17 - Shukra Pharmaceuticals Limited has informed the Exchange about General Updates

2026-08-14

General Updates

2026-08-14 - Shukra Pharmaceuticals Limited has informed the Exchange about General Updates

2026-08-14

General Updates

2026-08-14 - Shukra Pharmaceuticals Limited has informed the Exchange about General Updates

2026-08-14

General Updates

2026-08-14 - Shukra Pharmaceuticals Limited has informed the Exchange about General Updates

News

Recent coverage and analyst commentary for SHUKRAPHAR

Loading news…

🤖

AI Stock Analyst

Shukra Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1930.45

38.29

463179.62

0.83

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9165.00

83.18

243301.95

0.33

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4958.95

86.48

188622.52

0.77

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1164.05

25.73

116114.43

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1418.00

33.99

114554.33

0.92

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1860.00

91.92

100498.07

0.11

362.07

123.94

2026.31

29.10

18.20

31.50

LUPIN

2150.00

17.78

98312.16

0.84

1416.98

16.01

8276.89

34.28

28.86

29.59

DRREDDY

1171.00

30.33

97741.02

0.68

435.60

-69.10

8099.80

-5.21

13.75

10.63

MANKIND

2360.00

47.72

97478.64

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

AUROPHARMA

1683.00

26.08

96836.10

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2464.20

38.68

69545.80

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

SHUKRAPHAR

44.45

88.59

1954.09

0.02

12.96

—

23.52

77.26

21.80

81.39

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

Operating Profit

-0

OPM %

1.74%

20.66%

50.56%

40.72%

25.47%

12.05%

37.24%

55.09%

24.49%

-6.97%

69.32%

10.95%

90.15%

Other Income

Interest

Depreciation

Tax %

2.33%

-0.21%

1.15%

23.75%

38.75%

38.64%

22.68%

28.80%

24.82%

-1090.00%

24.11%

564.86%

25.75%

Net Profit

-2

-0

Equity Capital

Reserves

Promoter Pledge %

0.00%

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

Operating Profit

—

OPM %

—

Other Income

Interest

Depreciation

Tax %

-92

Net Profit

EPS

—

Dividend Payout %

—

Minority Interest

Share of Associates

Adjusted EPS

—

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

LIABILITIES

Equity Capital

Trade Payables

Total Liabilities

ASSETS

Capital Work in Progress

Cash & Bank

Total Assets

Total Debt

Net Working Capital

Contingent Liabilities

Book Value per Share

89.89

93.10

95.86

98.20

98.43

99.63

104.43

64.63

52.67

1.44

Face Value

10.00

1.00

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

-0

-5

Cash from Investing

-0

-1

-5

-2

-3

-2

-4

-1

Cash from Financing

-1

-7

-5

-1

-0

Free Cash Flow

-1

-4

-2

-1

-7

OCF / Net Profit

22.82

-0.59

1.59

0.56

34.83

2.86

10.64

0.72

-0.28

0.83

Cumulative 5-Year FCF

-7

-11

-3

-0

-5

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

0.76

3.21

3.36

2.95

0.23

1.20

4.79

11.26

16.94

0.22

Book Value (₹)

89.89

93.10

95.86

98.20

98.43

99.63

104.43

64.63

52.67

1.44

Dividend per Share (₹)

0.00

0.50

0.00

0.50

1.00

0.01

Cash EPS (₹)

0.02

0.03

0.04

0.05

0.06

0.08

0.40

0.47

0.29

PROFITABILITY

Operating Margin %

28.26%

29.70%

29.95%

25.53%

11.29%

16.08%

14.48%

11.15%

26.02%

39.06%

Net Margin %

2.46%

9.76%

9.12%

6.99%

0.26%

1.68%

3.66%

7.49%

24.86%

29.38%

ROE %

0.85%

3.51%

3.55%

3.04%

0.23%

1.21%

4.70%

21.16%

44.70%

15.90%

ROCE %

2.40%

7.41%

5.94%

3.62%

0.77%

0.54%

5.79%

18.85%

44.24%

21.80%

0.67%

2.78%

2.44%

1.76%

0.11%

0.54%

2.12%

8.01%

24.26%

11.63%

EFFICIENCY

Debtor Days

121

171

228

177

288

153

117

134

186

Inventory Days

Payable Days

245

526

872

563

762

246

170

168

370

-98

-341

-632

-364

-423

-43

-31

-20

-115

FINANCIAL HEALTH

Debt to Equity (x)

0.00x

0.24x

0.39x

0.52x

0.63x

0.21x

0.20x

0.05x

0.07x

Interest Coverage (x)

256.48x

182.99x

24.45x

1166.32x

84.02x

3.94x

4.55x

16.82x

70.77x

23.42x

8.06x

4.12x

3.11x

2.77x

2.07x

2.28x

1.28x

1.25x

3.97x

3.79x

GROWTH

Revenue Growth %

87.35%

6.46%

4.03%

5.91%

109.31%

-5.49%

82.97%

187.19%

26.75%

-56.30%

Operating Profit Growth %

57.96%

11.52%

12.87%

-2.27%

-8.15%

16.13%

64.81%

121.12%

238.70%

-23.77%

Net Profit Growth %

-8.98%

321.94%

4.56%

-12.12%

-92.29%

428.31%

299.10%

486.99%

320.68%

-48.35%

0.00%

50.47%

-98.71%

VALUATION

P/E (x)

0.00x

0.48x

99.91x

P/B (x)

0.00x

6.20x

15.23x

Dividend Yield %

0.00%

0.31%

0.05%

0.00x

15.78x

56.02x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

50.96

FIIs

0.00

0.11

Government

0.00

48.93

48.92

Shukra Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Shukra Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI